Institutional Manager · CIK 0001826434
Tri Locum Partners LP
NEW YORK, NY · File #028-21000
Latest AUM
$770.1M
Positions
15
Top-10 Concentration
80.1%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | DANAHER CORPORATION | 235851102 | +346,875 | +$79.4M | $0 |
| NEW | ELI LILLY & CO | LLY | +63,284 | +$68.0M | $0 |
| ADD | JOHNSON & JOHNSON | JNJ | +300,312 | +$62.1M | +$6.5M |
| NEW | BOSTON SCIENTIFIC CORP | BSX | +520,508 | +$49.6M | $0 |
| NEW | TEVA PHARMACEUTICAL INDS LTD | 881624209 | +1,435,865 | +$44.8M | $0 |
| NEW | IONIS PHARMACEUTICALS INC | IONS | +557,174 | +$44.1M | $0 |
| EXITED | MERCK & CO INC | 58933Y105 | -446,874 | -$37.5M | $0 |
| NEW | NUVALENT INC | NUVL | +307,371 | +$30.9M | $0 |
| EXITED | SOLENO THERAPEUTICS INC | 834203309 | -450,585 | -$30.5M | $0 |
| NEW | DEXCOM INC | DXCM | +421,600 | +$28.0M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202515 pos · $770.1M
- 13F HOLDINGS REPORTQ/E Sep 202518 pos · $435.1M
- 13F HOLDINGS REPORTQ/E Jun 202523 pos · $329.5M
- 13F HOLDINGS REPORTQ/E Mar 202522 pos · $194.9M
- 13F HOLDINGS REPORTQ/E Dec 202428 pos · $482.7M
- 13F HOLDINGS REPORTQ/E Sep 202420 pos · $417.4M
- 13F HOLDINGS REPORTQ/E Jun 202425 pos · $395.5M
- 13F HOLDINGS REPORTQ/E Mar 202427 pos · $288.4M
- 13F HOLDINGS REPORTQ/E Dec 202361 pos · $312.8M
Top 15 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | JOHNSON & JOHNSON | JNJ | 603,143 | $124.8M | 16.21% |
| 2 | DANAHER CORPORATION | 235851102 | 346,875 | $79.4M | 10.31% |
| 3 | ELI LILLY & CO | LLY | 63,284 | $68.0M | 8.83% |
| 4 | UNITED THERAPEUTICS CORP DEL | UTHR | 120,921 | $58.9M | 7.65% |
| 5 | ASCENDIS PHARMA A/S | ASND | 265,015 | $56.5M | 7.34% |
| 6 | MADRIGAL PHARMACEUTICALS INC | MDGL | 86,023 | $50.1M | 6.50% |
| 7 | BOSTON SCIENTIFIC CORP | BSX | 520,508 | $49.6M | 6.44% |
| 8 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 1,435,865 | $44.8M | 5.82% |
| 9 | IONIS PHARMACEUTICALS INC | IONS | 557,174 | $44.1M | 5.72% |
| 10 | VERA THERAPEUTICS INC | VERA | 805,689 | $40.8M | 5.30% |
| 11 | AXSOME THERAPEUTICS INC | AXSM | 201,627 | $36.8M | 4.78% |
| 12 | ARGENX SE | ARGX | 37,653 | $31.7M | 4.11% |
| 13 | NUVALENT INC | NUVL | 307,371 | $30.9M | 4.01% |
| 14 | DEXCOM INC | DXCM | 421,600 | $28.0M | 3.63% |
| 15 | DIANTHUS THERAPEUTICS INC | DNTH | 622,403 | $25.6M | 3.33% |